The Cigna Group (NYSE:CI) Price Target Lowered to $339.00 at Barclays

The Cigna Group (NYSE:CI) had its target price decreased by equities research analysts at Barclays from $420.00 to $339.00 in a report released on Friday,Benzinga reports. The brokerage currently has an “overweight” rating on the health services provider’s stock. Barclays‘s target price points to a potential upside of 20.03% from the stock’s current price.

CI has been the topic of a number of other research reports. Truist Financial dropped their price target on shares of The Cigna Group from $420.00 to $390.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Royal Bank of Canada dropped their price target on shares of The Cigna Group from $384.00 to $377.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. Piper Sandler reaffirmed an “overweight” rating and set a $394.00 price target (up previously from $392.00) on shares of The Cigna Group in a report on Tuesday, November 5th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $400.00 price target on shares of The Cigna Group in a report on Wednesday, October 23rd. Finally, StockNews.com downgraded shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. One investment analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, The Cigna Group currently has an average rating of “Buy” and a consensus price target of $390.14.

The Cigna Group Stock Down 6.9 %

Shares of The Cigna Group stock opened at $282.42 on Friday. The Cigna Group has a 1 year low of $262.03 and a 1 year high of $370.83. The company has a 50-day moving average of $295.09 and a 200 day moving average of $324.69. The firm has a market cap of $78.56 billion, a price-to-earnings ratio of 26.64, a PEG ratio of 0.82 and a beta of 0.54. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.72 and a quick ratio of 0.72.

The Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. During the same quarter in the previous year, the company earned $6.79 EPS. As a group, sell-side analysts anticipate that The Cigna Group will post 28.5 earnings per share for the current fiscal year.

Hedge Funds Weigh In On The Cigna Group

Several hedge funds have recently modified their holdings of CI. Ulland Investment Advisors LLC lifted its holdings in shares of The Cigna Group by 2,500.0% in the 3rd quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock valued at $36,000 after acquiring an additional 100 shares during the last quarter. Prospera Private Wealth LLC bought a new stake in The Cigna Group in the third quarter worth about $37,000. Collier Financial bought a new stake in The Cigna Group in the fourth quarter worth about $32,000. ORG Wealth Partners LLC bought a new stake in The Cigna Group in the fourth quarter worth about $34,000. Finally, Harbor Capital Advisors Inc. bought a new stake in The Cigna Group in the third quarter worth about $45,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.